| 3SBio Inc. Announces SFDA Approval of High-Dose EPIAO - PR Newswire (press release) |
|
|
PR Newswire (press release) Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. With headquarters and GMP-certified manufacturing facilities in Shenyang, PRC, |